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Optimising antisense oligonucleotide-mediated exon skipping for
Duchenne muscular dystrophy
1. When optimising a drug dosage regimen, balancing on-target eff ects (in muscle) 
and off - target eff ects (in other organs) is required (this thesis, chapter 3).
2. Th e dystrophin protein has a long half-life outliving AON and skipped transcript, 
which facilitates the use of intermittent (on/off ) scheduling to reduce side eff ects 
(this thesis, chapter 4).
3. While searching for compounds that enhance exon skipping, the focus should 
not only be effi  cacy at the point of interest, because off -target skipping eff ects 
increase the chance of toxicity (this thesis; chapter 5).
4. Th e use of prednisone or prednisolone does not aff ect the effi  cacy of AONs, so it 
does not impede participation in clinical trials, but it does infl uence functional 
outcomes and should be taken into account as a covariate (this thesis, chapter 6; 
Henricson EK (2013), Muscle Nerve; 48: 55-67).
5. Lack of reproducibility of published results is oft en a problem (this thesis, 
chapter 7).
6. Th ere should be more eff ort spent to publish and communicate negative results to 
prevent unnecessary repetition and waste of time and money.
7. For therapeutic approaches the feasibility of translation into humans should be 
taken into account.
8. It is unethical to post no results of clinical trials in case of unwanted fi ndings.
9. At the moment all scientifi c research should have direct economic benefi t to ob-
tain research funding, which compromises fundamental science. Th is is harmful 
in the long run, since basic science is essential for translational science.
10. Instead of humanizing mouse models, we had better make humans more murine, 
since mice are a lot easier to cure than patients.
11. Th e work of science has nothing whatever to do with consensus. Consensus is the 
business of politics. (……) In science consensus is irrelevant. What are relevant 
are reproducible results (Michael Crichton, 2003).
12. Even though the positive correlation between chocolate consumption and num-
ber of Nobel price laureates per country (Messerli FH (2012) N Engl J Med; 367: 
1562-1564) might be a coincidence, it is worth trying.
